pubmed.ncbi.nlm.nih.gov

Polyglucosan storage myopathies - PubMed

Review

Polyglucosan storage myopathies

Carola Hedberg-Oldfors et al. Mol Aspects Med. 2015 Dec.

Abstract

Polyglucosan is an amylopectin-like polysaccharide associated with defective glycogen metabolism and, unlike normal glycogen, it is to some extent resistant to α-amylase digestion. It also has a characteristic fibrillar appearance under the electron microscope. Polyglucosan may aggregate into dense inclusions known as polyglucosan bodies. Its accumulation can be found in various tissues to some degree in normal ageing, but it is also the hallmark of some diseases associated with defects in glycogen metabolism. These diseases frequently involve both skeletal and cardiac muscle tissue, causing myopathy with muscle weakness and wasting, and cardiomyopathy with arrhythmia, conduction block, and cardiac failure. Mutations in eight human genes are known to be associated with polyglucosan storage involving muscle, namely GYG1, GBE1, RBCK1 (HOIL-1), PFKM, EPM2A, EPM2B (NHLRC1), PRDM8, and PRKAG2. There is also a common equine polysaccharide storage myopathy belonging to this group of diseases involving the GYS1 gene. The pathogenic mechanisms that cause the abnormal glycogen accumulation appearing as polyglucosan have been studied in some of these diseases. In most cases the pathogenesis is largely unknown. In this review, we summarize the polyglucosan storage diseases from a clinical, morphological, and genetic standpoint. We also identify some important similarities and differences regarding the morphological appearance of polyglucosan accumulation and discuss pathogenic pathways.

Keywords: Cardiomyopathy; Glycogen; Metabolism; Muscle disease; Muscle glycogen storage disorders; Polyglucosan; Polysaccharide storage.

PubMed Disclaimer

Cited by

New insights on fibrodysplasia ossificans progressiva: discussion of an autoptic case report and brief literature review.
Bolcato V, Carelli C, Visonà SD, Reguzzoni M, Rocco MD, Radogna A, Tronconi LP, Moretti M. Bolcato V, et al. Intractable Rare Dis Res. 2021 May;10(2):136-141. doi: 10.5582/irdr.2021.01021. Intractable Rare Dis Res. 2021. PMID: 33996361 Free PMC article.
Glycogen synthase downregulation rescues the amylopectinosis of murine RBCK1 deficiency.
Nitschke S, Sullivan MA, Mitra S, Marchioni CR, Lee JPY, Smith BH, Ahonen S, Wu J, Chown EE, Wang P, Petković S, Zhao X, DiGiovanni LF, Perri AM, Israelian L, Grossman TR, Kordasiewicz H, Vilaplana F, Iwai K, Nitschke F, Minassian BA. Nitschke S, et al. Brain. 2022 Jul 29;145(7):2361-2377. doi: 10.1093/brain/awac017. Brain. 2022. PMID: 35084461 Free PMC article.
GYS1 or PPP1R3C deficiency rescues murine adult polyglucosan body disease.
Chown EE, Wang P, Zhao X, Crowder JJ, Strober JW, Sullivan MA, Xue Y, Bennett CS, Perri AM, Evers BM, Roach PJ, Depaoli-Roach AA, Akman HO, Pederson BA, Minassian BA. Chown EE, et al. Ann Clin Transl Neurol. 2020 Nov;7(11):2186-2198. doi: 10.1002/acn3.51211. Epub 2020 Oct 9. Ann Clin Transl Neurol. 2020. PMID: 33034425 Free PMC article.
A novel likely pathogenic homozygous RBCK1 variant in dilated cardiomyopathy with muscle weakness.
MozafaryBazargany M, Esmaeili S, Hesami M, Houshmand G, Mahdavi M, Maleki M, Kalayinia S. MozafaryBazargany M, et al. ESC Heart Fail. 2024 Jun;11(3):1472-1482. doi: 10.1002/ehf2.14702. Epub 2024 Feb 8. ESC Heart Fail. 2024. PMID: 38329383 Free PMC article.
SGK1 (glucose transport), dishevelled2 (wnt signaling), LC3/p62 (autophagy) and p53 (apoptosis) proteins are unaltered in Lafora disease.
Wang P, Israelian L, Xue Y, Song S, Attisano L, Minassian BA. Wang P, et al. All Results J Biol. 2016;7(3):28-33. All Results J Biol. 2016. PMID: 29152446 Free PMC article.

Polyglucosan storage myopathies - PubMed